KGI SCOP Club Presents "Just in Time" Coffee Chat! - Keck Graduate Institute February 24, 2021, 12:00 pm Skip to main content
Loading Events

« All Events

  • This event has passed.

Please join KGI SCOP in welcoming alumni Jonathan Naab (Amgen, Senior Associate Clinical Supply Chain) and Stephen Greco (Amgen, Senior Associate Project Management) for a virtual coffee chat. This will be an informal discussion where attendees may have a dialogue with Jonathan and Stephen about:

  • How their interests in SCM/Ops developed
  • Their day-to-day responsibilities in their respective roles
  • Their impact at the company and on the lives of patients
  • How to get started in an SCM/Ops career in the life sciences industry

Date: Wednesday, February 24, 2021

Time: 12:00 PM – 1:00 p.m. PST


Questions? Please contact us at

Take a look at our speaker bios below!

Jonathan Baan Naab, Sr. Associate Global Clinical Supply Chain, Amgen

As a clinical supply chain professional, Jonathan sits at the helm of translating toxicology, pharmacokinetics, drug metabolism, and study requirements into an actionable plan. His responsibilities also include coordinating labeling, packaging, and shipment of packed supplies to study depots and sites. Forecasting of study demands also falls within the purview of Jonathan’s role.

Jonathan also serves as one of the lead planners for AMG 510, Amgen’s groundbreaking KRAS inhibitor molecule.

Prior to his clinical supply chain career, Jonathan worked as an analyst at the food and drugs authority in Ghana responsible for preparing media and controlling the micro-environment for optimization of samples under microbiological analysis.

Jonathan holds an MBS from Keck Graduate Institute and a bachelors in Applied Biology from the University for Development studies from his native country, Ghana.

Stephen Greco, Sr. Associate Project Management, Amgen

Stephen graduated from Keck Graduate Institute in 2019 with a Master of Business and Science degree, concentrated in Bioprocessing. He Interned with Amgen in the Summer of 2018 in the Supply Chain Excellence and Innovation group. Upon graduating from KGI, Stephen began working at Amgen, supporting clinical and commercial manufacturing as project manager. He is currently the Downstream New Product Introduction (NPI) Lead for Blincyto, Amgen’s first FDA approved BiTE molecule, where he acts as a bridge between technical teams, clinical supply chain and manufacturing in support of commercial manufacturing tech transfer.


United States